Drug Search Results
More Filters [+]

Articaine

Alternative Names: articaine, orabloc, ultacan forte, septocaine, ultacan, articadent, zorcaine
Latest Update: 2024-11-25
Latest Update Note: Clinical Trial Update

Product Description

Articaine is an intermediate-potency, short-acting amide local anesthetic with a fast metabolism due to an ester group in its structure. It is effective with local infiltration or peripheral nerve block in dentistry, when administered as a spinal, epidural, ocular, or regional nerve block, or when injected intravenously for regional anesthesia. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417979/)

Mechanisms of Action: Nerve Impulse Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Topical,Ophthalmic,Injection

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Croatia | Cyprus | Czech | Denmark | Ecuador | Egypt | Estonia | Finland | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Anastesia Related

Known Adverse Events: Headache | Pain Unspecified

Company: American Genomics
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Articaine

Countries in Clinic: United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Anesthesia Related|Infertility

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

AG-920-CS303

P3

Completed

Infertility|Anesthesia Related

2022-12-07

AG-920-CS304

P3

Completed

Anesthesia Related

2022-05-27

Recent News Events